BioSpace News Archive

Novocure announced that Bill Doyle, Novocure’s Executive Chairman, will participate in the Jefferies 2019 Global Healthcare Conference on June 4, 2019, in New York City.

Kelyniam Global, a maker of custom cranial and craniofacial implants, announced that it has received premarket approval from the Food and Drug Administration for a new 510 application that allows for unique modifications to their PEEK cranio-maxillofacial implant product line.

IBE President Dr. Martin Brodie Receives Epilepsy Lifetime Accelerator Award at AEDD

Green Growth Brands, Inc. is pleased to announce that its board of directors has approved the grant of an aggregate of 595,000 restricted share units under the Company’s equity incentive plan to certain of its employees.

Name Reflects Our Focus on Defeating Cancer and Allergic Inflammatory Diseases

Full Results from Phase 3 ARTEMIS Study Will Be Featured

Experts from the ProfNet network who are available to discuss timely issues in your coverage area.

The Illinois Mesothelioma Victims Center is urging a person who has just been diagnosed with mesothelioma in Illinois to call them anytime at 800-714-0303 for on the spot access to attorney Erik Karst, the founding partner of the law firm of Karst von Oiste.

NeoImmuneTech, Inc. announced that the U.S. Food and Drug Administration has allowed the Center for Cancer Research, National Cancer Institute to proceed with an Investigational New Drug application application for Hyleukin-7™, a long acting T cell amplifier, to begin a clinical trial aiming to enhance the immune reconstitution and vaccine responses in elderly cancer survivors following chemotherapy.

How data and technology enable more patients to receive the most promising new experimental therapies during a clinical trial - a collaboration with Friends of Cancer Research